title: Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab?
authors: M J H
authors: MJ
authors: Boumans
authors: K
authors: K
authors: Vos
authors: D M
authors: DM
authors: Gerlag
authors: P P
authors: PP
authors: Tak
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000191:economics; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000191:economics; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics; D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D019233:Retreatment; D000069283:Rituximab; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab